{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T07:01:46Z","timestamp":1783234906695,"version":"3.54.6"},"reference-count":27,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2010,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            From 2002 to 2008, there was a significant increase in extended-spectrum beta-lactamase (ESBL)-positive\n            <jats:italic>Escherichia coli<\/jats:italic>\n            isolates in European intra-abdominal infections, from 4.3% in 2002 to 11.8% in 2008 (\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.001), but not for ESBL-positive\n            <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n            isolates (16.4% to 17.9% [\n            <jats:italic>P<\/jats:italic>\n            &gt; 0.05]). Hospital-associated isolates were more common than community-associated isolates, at 14.0% versus 6.5%, respectively, for\n            <jats:italic>E. coli<\/jats:italic>\n            (\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.001) and 20.9% versus 5.3%, respectively, for\n            <jats:italic>K. pneumoniae<\/jats:italic>\n            (\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.01). Carbapenems were consistently the most active drugs tested.\n          <\/jats:p>","DOI":"10.1128\/aac.00265-10","type":"journal-article","created":{"date-parts":[[2010,4,27]],"date-time":"2010-04-27T02:19:17Z","timestamp":1272334757000},"page":"3043-3046","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":71,"title":["Incidence and Antimicrobial Susceptibility of\n            <i>Escherichia coli<\/i>\n            and\n            <i>Klebsiella pneumoniae<\/i>\n            with Extended-Spectrum \u03b2-Lactamases in Community- and Hospital-Associated Intra-Abdominal Infections in Europe: Results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART)"],"prefix":"10.1128","volume":"54","author":[{"given":"Stephen P.","family":"Hawser","sequence":"first","affiliation":[{"name":"IHMA Europe Sa\u0300rl, 1066 Epalinges, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel K.","family":"Bouchillon","sequence":"additional","affiliation":[{"name":"International Health Management Associates, Inc., Schaumburg, Illinois 60173-3817"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl J.","family":"Hoban","sequence":"additional","affiliation":[{"name":"International Health Management Associates, Inc., Schaumburg, Illinois 60173-3817"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Badal","sequence":"additional","affiliation":[{"name":"International Health Management Associates, Inc., Schaumburg, Illinois 60173-3817"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Canto\u0301n","sequence":"additional","affiliation":[{"name":"Servicio de Microbiologi\u0301a, Hospital Universitario Ramo\u0301n y Cajal and CIBER en Epidemiologi\u0301a y Salud Pu\u0301blica (CIBERESP), Madrid, Spain"},{"name":"Instituto Ramo\u0301n y Cajal de Investigacio\u0301n Sanitaria (IRYCIS), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Baquero","sequence":"additional","affiliation":[{"name":"Servicio de Microbiologi\u0301a, Hospital Universitario Ramo\u0301n y Cajal and CIBER en Epidemiologi\u0301a y Salud Pu\u0301blica (CIBERESP), Madrid, Spain"},{"name":"Instituto Ramo\u0301n y Cajal de Investigacio\u0301n Sanitaria (IRYCIS), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2008.0020"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/604713"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2006.7.537"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2007.01850.x"},{"key":"e_1_3_2_6_2","unstructured":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 2008"},{"key":"e_1_3_2_7_2","unstructured":"Performance standards for antimicrobial susceptibility testing. 2008"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.2807\/ese.13.47.19044-en"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/msj.20070"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2005.10.001"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.01.017"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00426-09"},{"key":"e_1_3_2_13_2","unstructured":"Reference deleted."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2005.04.004"},{"key":"e_1_3_2_15_2","unstructured":"Reference deleted."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00651-08"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-009-0801-x"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn169"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl483"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01284-07"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2008.12.001"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki166"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl199"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2006.08.016"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.10.4769-4775.2004"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02803.x"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2006.11.020"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn396"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00265-10","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00265-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T20:19:37Z","timestamp":1645474777000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00265-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.1128\/AAC.00265-10"],"URL":"https:\/\/doi.org\/10.1128\/aac.00265-10","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"2010-02-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-04-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}